A comparative effect of Lekhaniya Mahakashaya Ghan Vati and Mustadi Ghan Vati in the management of Dyslipidemia
- Conditions
- Health Condition 1: E782- Mixed hyperlipidemia
- Registration Number
- CTRI/2017/01/007642
- Lead Sponsor
- Govt Akhandanand Ayurved College and Hospital Bhadra Ahmedabad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
1.If any one or many parameters among lipid profile of an individual found to be in limit stated below,then the subject will be included in the study for objective criteria:
Serum cholesterol - 200mg/dl or more Serum triglycerides -150mg/dl or more
Serum LDL - 100mg/dl or more
Serum VLDL-10-30mg/dl or more
Serum HDL - <40mg/dl.
2.Patient’s ongoing anti-hyperlipidemic drugs will be stopped and wash out period will be specified.
3.The main signs and symptoms in the present study will be taken for subjective criteria are as follows-
weakness, Fatigue, Paraesthesia, Weight gain,
Angachalatva, Alasya, Kshudrashwas, Nidradhikya, Swedadhikya, Daurgandhya ,
Snigdhata, Atipipasa, Atikshudha, Angagaurava.
•Patient having age <18 or >60 yrs.
•Patient having serious cardiac problems- M.I., Cardiac Failure.
•Endocrinal disorders will not be taken for study like diabetes mellitus, hypothyroid.
•Patient having history of obesity and Hyperlipidemia due to drugs e.g. corticosteroids, Antidepressent drugs will not be taken for study.
•If Lipid profile parameters will come in very high range, patient will be excluded which is given below-
Serum cholesterol- >300mg/dl.
Serum triglycerides- >500mg/dl.
Serum LDL - >190mg/dl.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method After completion of the course of the treatment the result will be assessed on the basis of - lipid profile of patients before and after treatment and difference in the score of sign and symptoms of Medoroga and dyslipidemia.Timepoint: 6 weeks
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI